Germany
Tuberculosis profile
Population  2012 83 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.29 (0.28–0.29) 0.35 (0.34–0.35)
Mortality (HIV+TB only) <0.01 (<0.01–<0.01) 0 (0–0.01)
Prevalence  (includes HIV+TB) 6.4 (2.8–12) 7.8 (3.3–14)
Incidence  (includes HIV+TB) 4.6 (4.1–5.3) 5.6 (4.9–6.4)
Incidence (HIV+TB only) 0.034 (0.03–0.039) 0.04 (0.04–0.05)
Case detection, all forms (%) 87 (77–99)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 952 (28) Relapse 60 (24)
Smear-negative 0 (0) Treatment after failure 5 (2)
Smear-unknown / not done 1 605 (47) Treatment after default 17 (7)
Extrapulmonary 824 (24) Other 169 (67)
Other 6 (<1)      
Total new 3 387   Total retreatment 251  
           
Other (history unknown) 582        
Total new and relapse 3 447   Total cases notified 4 220  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 1.9 1.6 1.1
Age < 15 10 127 32
Laboratories 2012
Is second-line drug susceptibility testing available? Yes, in country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 74   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 70  
Retreatment 62  
TB/HIV 2012 Number (%)
TB patients with known HIV status    
HIV-positive TB patients    
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 1.5 (1–2) 10 (5.5–17)
MDR-TB cases among notified pulmonary
TB cases
37 (26–53) 26 (14–44)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 2 361 (93%) 128 (51%) 2 818
Laboratory-confirmed MDR-TB cases 32 12 64
Patients started on MDR-TB treatment     63
Financing TB control 2013
National TB programme budget (US$ millions)  
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-20 Data: www.who.int/tb/data